Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II preventive topical betamethasone study for anti-EGFR-induced folliculitis
2007-002913-38Phase 2Active
- Sponsor
- Centre Oscar Lambret
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of betamethasone dipropionate in folliculitis (2 cohorts), sponsored by Centre Oscar Lambret. Primary endpoints: Cutaneous toxicity / folliculitis incidence and grade and Frequency of grade 1-3 folliculitis under cetuximab and erlotinib. Started Jun 2007; status: active.
02
Drugs
betamethasone dipropionate
03
Conditions
folliculitis
Beyond the preview
Go deeper on 2007-002913-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002913-38.